198 related articles for article (PubMed ID: 33463129)
1. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
[TBL] [Abstract][Full Text] [Related]
2. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
[TBL] [Abstract][Full Text] [Related]
3. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
Kikushige Y
Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
[TBL] [Abstract][Full Text] [Related]
4. Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway.
Luo LH; Li DM; Wang YL; Wang K; Gao LX; Li S; Yang JG; Li CL; Feng W; Guo H
Biochem Biophys Res Commun; 2017 Sep; 491(4):966-972. PubMed ID: 28756232
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide augments oridonin-induced efferocytosis by human histocytic lymphoma U937 cells via autophagy and the NF-κB-COX-2-IL-1β pathway.
Zang L; He H; Ye Y; Liu W; Fan S; Tashiro S; Onodera S; Ikejima T
Free Radic Res; 2012 Oct; 46(10):1207-19. PubMed ID: 22670565
[TBL] [Abstract][Full Text] [Related]
6. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
Ikezoe T; Yang Y; Bandobashi K; Saito T; Takemoto S; Machida H; Togitani K; Koeffler HP; Taguchi H
Mol Cancer Ther; 2005 Apr; 4(4):578-86. PubMed ID: 15827331
[TBL] [Abstract][Full Text] [Related]
7. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.
Gonçalves Silva I; Yasinska IM; Sakhnevych SS; Fiedler W; Wellbrock J; Bardelli M; Varani L; Hussain R; Siligardi G; Ceccone G; Berger SM; Ushkaryov YA; Gibbs BF; Fasler-Kan E; Sumbayev VV
EBioMedicine; 2017 Aug; 22():44-57. PubMed ID: 28750861
[TBL] [Abstract][Full Text] [Related]
8. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
9. Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia.
Zhang W; Lu Y; Zhen T; Chen X; Zhang M; Liu P; Weng X; Chen B; Wang Y
Front Med; 2019 Jun; 13(3):388-397. PubMed ID: 30206768
[TBL] [Abstract][Full Text] [Related]
10. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.
Chen RY; Xu B; Chen SF; Chen SS; Zhang T; Ren J; Xu J
World J Gastroenterol; 2014 Oct; 20(40):14895-903. PubMed ID: 25356049
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.
Zhang W; Zhang Y; He Y; Wang X; Fang Q
Exp Cell Res; 2019 Mar; 376(2):124-132. PubMed ID: 30763585
[TBL] [Abstract][Full Text] [Related]
12. TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines.
Rezaei M; Ghanadian M; Ghezelbash B; Shokouhi A; Bazhin AV; Zamyatnin AA; Ganjalikhani-Hakemi M
Front Immunol; 2023; 14():1267578. PubMed ID: 38022614
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
[TBL] [Abstract][Full Text] [Related]
14. TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1.
Shapourian H; Ghanadian M; Eskandari N; Shokouhi A; Demirel GY; Bazhin AV; Ganjalikhani-Hakemi M
BMC Cancer; 2024 Jan; 24(1):125. PubMed ID: 38267906
[TBL] [Abstract][Full Text] [Related]
15. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
[TBL] [Abstract][Full Text] [Related]
16. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.
Yasinska IM; Sakhnevych SS; Pavlova L; Teo Hansen Selnø A; Teuscher Abeleira AM; Benlaouer O; Gonçalves Silva I; Mosimann M; Varani L; Bardelli M; Hussain R; Siligardi G; Cholewa D; Berger SM; Gibbs BF; Ushkaryov YA; Fasler-Kan E; Klenova E; Sumbayev VV
Front Immunol; 2019; 10():1594. PubMed ID: 31354733
[TBL] [Abstract][Full Text] [Related]
17. Oridonin Attenuates TNBS-induced Post-inflammatory Irritable Bowel Syndrome via PXR/NF-κB Signaling.
Shao YY; Guo Y; Feng XJ; Liu JJ; Chang ZP; Deng GF; Xu D; Gao JP; Hou RG
Inflammation; 2021 Apr; 44(2):645-658. PubMed ID: 33125572
[TBL] [Abstract][Full Text] [Related]
18. Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.
Zhang Y; Jiang N; Zhang T; Chen R; Feng Y; Sang X; Yang N; Chen Q
Parasit Vectors; 2019 Nov; 12(1):534. PubMed ID: 31711531
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9 contributes to the pathogenesis of atopic dermatitis
Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
Front Immunol; 2022; 13():952338. PubMed ID: 35967337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]